Patient page. Slowing down a "slow" movement disorder: selegiline's benefit in treating Parkinson disease

Neurology. 2006 Apr 25;66(8):E28-9. doi: 10.1212/01.wnl.0000217547.43970.ea.
No abstract available

Publication types

  • Comparative Study
  • Patient Education Handout
  • Review

MeSH terms

  • Disease Progression
  • Drug Therapy, Combination
  • Humans
  • Levodopa / therapeutic use
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / physiopathology*
  • Selegiline / therapeutic use*

Substances

  • Selegiline
  • Levodopa